Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-136041
Filing Date
2022-05-02
Accepted
2022-05-02 11:44:30
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFA14A d289121ddefa14a.htm DEFA14A 23572
2 GRAPHIC g2891211b.jpg GRAPHIC 1440
3 GRAPHIC g2891211c.jpg GRAPHIC 1446
4 GRAPHIC g289121g92a01.jpg GRAPHIC 5334
5 GRAPHIC g289121g92d04.jpg GRAPHIC 1805
6 GRAPHIC g289121g92e05.jpg GRAPHIC 1633
7 GRAPHIC g289121g92f06.jpg GRAPHIC 2251
  Complete submission text file 0001193125-22-136041.txt   44664
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33277 | Film No.: 22880234
SIC: 2834 Pharmaceutical Preparations